Select Medical Holdings Corporation
NYSE:SEM · New York Stock Exchange
+$0.02 today
Vol 0.64M · Avg 1.75M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
8.6%
avg 17.8%
ROIC
5.2%
avg 5.8%
ROA
2.5%
avg 3.0%
Analysis
ROE is currently the strongest return metric at 8.6% versus its period average of 17.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Robert A. Ortenzio | Co-Founder & Executive Chairman | $3.05M | — | 68 | $34,696.00 | 0.03% |
Martin F. Jackson | Senior Executive Vice President of Strategic Finance & Operations | $1.87M | — | 71 | $194,710.00 | 0.16% |
Thomas Mullin | Chief Executive Officer | $1.62M | — | 42 | $391,709.00 | 0.32% |
John A. Saich | President | $1.61M | — | 57 | $135,084.00 | 0.11% |
Michael F. Malatesta | Executive Vice President & Chief Financial Officer | $1.51M | — | 56 | $194,710.00 | 0.16% |
Robert G. Breighner Jr. | Senior Vice President of Compliance & Audit | — | — | 57 | $34,696.00 | 0.03% |
Bridget Sherick | Senior Vice President of Accounting for Shared Services | — | — | — | — | — |
Brian R. Rusignuolo | Executive Vice President & Chief Information Officer | — | — | 50 | $361,370.00 | 0.29% |
Christopher S. Weigl | Senior Vice President, Controller & Chief Accounting Officer | — | — | 42 | $54,254.00 | 0.04% |
John Duggan | Executive Vice President, General Counsel & Secretary | — | — | 62 | $135,084.00 | 0.11% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -1.9% | +2.5% (13yr)2 analysts |
| Revenue | N/A | N/A | +8.3% | +4.1% (13yr)2 analysts |
| Net Income | N/A | N/A | -4.1% | +1.9% (13yr)2 analysts |
| EBIT | N/A | N/A | -6.6% | +4.9% (13yr)2 analysts |
Analysis
Recent growth has been strongest in Revenue at +8.3% over three years. Forward estimates point to EBIT at +4.9% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
LifeStance Health Group, Inc.
NASDAQ:LFST
$3.42B
National HealthCare Corporation
AMEX:NHC
$3.02B
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
$2.26B
Astrana Health, Inc.
NASDAQ:ASTH
$1.94B
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
$1.92B
Pediatrix Medical Group, Inc.
NYSE:MD
$1.90B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.67B
Healthcare Services Group, Inc.
NASDAQ:HCSG
$1.56B
Ardent Health Partners, LLC
NYSE:ARDT
$1.29B
U.S. Physical Therapy, Inc.
NYSE:USPH
$958.78M
Who manages SEM?
Select Medical Holdings Corporation (SEM) lists 10 active executives. The top listed executive is Robert A. Ortenzio, Co-Founder & Executive Chairman.
Are SEM insiders buying or selling?
Recent insider activity shows net selling of $146.87M.
Explore More
Continue the stock analysis
Jump to another research area for this company.